UA97096C2 - Выделенное антитело, которое специфически связывает рецептор-2 trail (tr-2) - Google Patents

Выделенное антитело, которое специфически связывает рецептор-2 trail (tr-2)

Info

Publication number
UA97096C2
UA97096C2 UAA200804023A UAA200804023A UA97096C2 UA 97096 C2 UA97096 C2 UA 97096C2 UA A200804023 A UAA200804023 A UA A200804023A UA A200804023 A UAA200804023 A UA A200804023A UA 97096 C2 UA97096 C2 UA 97096C2
Authority
UA
Ukraine
Prior art keywords
antibody
specifically binds
trail receptor
isolated antibody
relates
Prior art date
Application number
UAA200804023A
Other languages
English (en)
Ukrainian (uk)
Inventor
Брайан Гліняк
Ксяо-Донг Янг
Шерон Вонг-Медден
Ян Фольтц
Ксяо Фенг
Елісон Фіч
Стівен Фостер
Рендалл Р. Кетчем
Original Assignee
Емджен Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Емджен Інк. filed Critical Емджен Інк.
Priority claimed from PCT/US2006/033763 external-priority patent/WO2007027713A2/en
Publication of UA97096C2 publication Critical patent/UA97096C2/ru

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Изобретение относится к выделенному антителу, которое специфически связывается с рецептором-2 TRAIL (TR-2), полинуклеотиду, который его кодирует, клетке-хозяину, способу получения данного антитела. Изобретение также относится к фармацевтической композиции, которая его содержит, а также к применению терапевтически эффективного количества антитела для изготовления лекарственного средства для лечения рака у пациента.
UAA200804023A 2005-08-31 2006-08-28 Выделенное антитело, которое специфически связывает рецептор-2 trail (tr-2) UA97096C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71343305P 2005-08-31 2005-08-31
PCT/US2006/033763 WO2007027713A2 (en) 2005-08-31 2006-08-28 Trail receptor 2 polypeptides and antibodies

Publications (1)

Publication Number Publication Date
UA97096C2 true UA97096C2 (ru) 2012-01-10

Family

ID=40079598

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200804023A UA97096C2 (ru) 2005-08-31 2006-08-28 Выделенное антитело, которое специфически связывает рецептор-2 trail (tr-2)

Country Status (3)

Country Link
CN (1) CN101300273B (ru)
UA (1) UA97096C2 (ru)
ZA (1) ZA200802575B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790663B2 (en) 2009-04-03 2014-07-29 Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences Antigenic determinants of human death receptor DR5
WO2011130324A1 (en) * 2010-04-13 2011-10-20 Medimmune, Llc Fibronectin type iii domain-based multimeric scaffolds
CN105050618B (zh) * 2012-06-21 2018-11-16 索伦托治疗有限公司 与c-Met结合的抗原结合蛋白
CN103333247B (zh) * 2013-05-30 2014-10-08 北京东方百泰生物科技有限公司 新型抗vegfr2的单克隆抗体及其制备与应用
CN106632607A (zh) * 2016-12-29 2017-05-10 华东理工大学 靶向survivin纳米抗体及其制备方法和应用
CN108855003B (zh) * 2018-06-28 2021-01-05 南开大学 一种用于清除血液中炎性因子的免疫吸附剂及其制备方法
CN114395034B (zh) * 2022-03-24 2022-08-05 中国科学院微生物研究所 一种高效中和新型冠状病毒的人源抗体及其应用
KR20250134237A (ko) * 2023-01-17 2025-09-10 수저우 유덴 바이오테크놀로지 씨오., 엘티디 Dr5 도메인 변이체 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI318983B (en) * 2000-05-02 2010-01-01 Uab Research Foundation An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
AU2002361784A1 (en) * 2001-12-20 2003-07-09 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors

Also Published As

Publication number Publication date
CN101300273B (zh) 2013-05-22
ZA200802575B (en) 2009-01-28
CN101300273A (zh) 2008-11-05

Similar Documents

Publication Publication Date Title
IL197721A (en) An isolated monoclonal antibody associated with Delta-Lake 4 (dll4), its pharmacological preparations, polynucleotides encoding them and their use in the manufacture of cancer drugs
UA94734C2 (ru) ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ
NO2017019I1 (no) Diarylhydantoinforbindelse, farmasøytisk sammensetning og anvendelse derav
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
WO2012024530A3 (en) Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
TW200716646A (en) (S)-N-methylnaltrexone
MX2011010390A (es) Conjugados, particulas, composiciones de agentes polimericos y metodos relacionados de uso.
EP4349868A3 (en) Humanized and chimeric monoclonal antibodies to cd47
MX2007008379A (es) Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones.
IN2014MN00139A (ru)
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
WO2006053049A3 (en) Herbal composition phy906 and its use in chemotherapy
MA32288B1 (fr) Nouveaux anticorps utiles pour le traitement du cancer
WO2013071056A3 (en) Combination drug therapy for the treatment of solid tumors
WO2009002808A3 (en) Quinazolinone compounds and methods of use thereof
WO2009062576A8 (en) Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
MX2009003039A (es) Utilizacion de un anticuerpo anti-cd151 para el tratamiento del cancer.
MX2009010269A (es) Metodos de tratamiento del cancer mediante administracion de combinaciones de interleucina-18 humana.
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
WO2007062413A3 (en) Use of parp-1 inhibitors
WO2010099139A3 (en) Combination of an either an anti-igf-ir- antibody or an igf binding protein and a small molecule igf-ir kinease inhibitor
UA97096C2 (ru) Выделенное антитело, которое специфически связывает рецептор-2 trail (tr-2)
IL164564A0 (en) Combination therapy for the treatment of cancer
PL1803456T3 (pl) Kompozycje farmaceutyczne zawierające L-733060 do zastosowania w leczeniu guzów nowotworowych